Dynamical effects of epigenetic silencing of 14-3-3sigma expression.

The development and progression of malignant tumours are often due to deregulated cell cycle control involving a plethora of different molecules. Among these, tumour suppressor proteins like p53 play a crucial role. p53 induces 14-3-3sigma, a multifunctional protein kinase inhibitor, centrally involved in cell cycle control and DNA damage repair after genotoxic stress. Recently, it has been shown that 14-3-3sigma is epigenetically silenced in a variety of tumours, which might contribute to tumour development and progression via impaired cell cycle control. In addition, p53, its inhibitor MDM2 and 14-3-3sigma form a signalling module in which 14-3-3sigma positively regulates the activity of p53 through feedback regulation. Here we present a mathematical model integrating the effects of 14-3-3sigma gene silencing, the dynamics of 14-3-3sigma induction and compartmentalisation by genotoxic stress and the role of interacting molecules p53 and MDM2. In vitro experiments with different melanoma cell lines were performed and our mathematical model was subjected to computer simulations to analyse different scenarios of activation depending on gene methylation status and DNA damage levels. Our analysis indicates that 14-3-3sigma expression is silenced by high gene methylation, but also that strong stimulation is necessary to induce 14-3-3sigma expression in cases of intermediate levels of gene methylation. More intriguingly, the model suggests that epigenetic silencing of 14-3-3sigma affects p53 dynamics in a synergistic way, such that the accumulative effect of partial downregulation of p53 expression and reduction of its nuclear fraction could affect drastically the activity of p53 as a transcription factor.

[1]  H. Spaink,et al.  Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3σ and 14-3-3ζ , 2004, Journal of Cell Science.

[2]  Sebastian Bohl,et al.  Computational processing and error reduction strategies for standardized quantitative data in biological networks , 2005, The FEBS journal.

[3]  Eva Balsa-Canto,et al.  Power-law models of signal transduction pathways. , 2007, Cellular signalling.

[4]  B. Gusterson,et al.  Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. , 2002, Cancer research.

[5]  Satoshi Inoue,et al.  Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.

[6]  Tomasz Lipniacki,et al.  Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.

[7]  Mong-Hong Lee,et al.  14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth , 2003, Molecular and Cellular Biology.

[8]  R. Marais,et al.  Melanoma biology and new targeted therapy , 2007, Nature.

[9]  L. Elmore,et al.  Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction* , 2002, The Journal of Biological Chemistry.

[10]  R. Spang,et al.  Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues , 2007, Clinical Cancer Research.

[11]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Gabriel,et al.  High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.

[13]  H. Hermeking,et al.  14-3-3 proteins in cell cycle regulation. , 2006, Seminars in cancer biology.

[14]  Mark E. Davis,et al.  Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging , 2006, Nucleic acids research.

[15]  K. Kinzler,et al.  14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.

[16]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[17]  H. Hermeking,et al.  Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression , 2004, Oncogene.

[18]  H. Hermeking The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[19]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[20]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[21]  Olaf Wolkenhauer,et al.  Dynamic properties of a delayed protein cross talk model , 2008, Biosyst..

[22]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[23]  H. Hermeking,et al.  Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation , 2005, Modern Pathology.

[24]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[25]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[26]  Yuquan Wei,et al.  Gene expression and methylation status of 14‐3‐3σ in human renal carcinoma tissues , 2008, IUBMB life.

[27]  John Jeremy Rice,et al.  A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Vera,et al.  14-3-3σ gene silencing during melanoma progression and its role in cell cycle control and cellular senescence , 2009, Molecular Cancer.

[29]  Hiromu Suzuki,et al.  Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2000, Oncogene.

[30]  M.-H. Lee,et al.  Roles for negative cell regulator 14-3-3σ in control of MDM2 activities , 2007, Oncogene.

[31]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[33]  L. Chin The genetics of malignant melanoma: lessons from mouse and man , 2003, Nature Reviews Cancer.

[34]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[35]  M. Sugiyama,et al.  Methylation and intratumoural heterogeneity of 14-3-3 σ in oral cancer , 2007 .

[36]  Satoshi Nishizuka,et al.  Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays. , 2007, Cancer research.

[37]  S. Schwarze,et al.  The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. , 2005, Neoplasia.

[38]  John R Yates,et al.  Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer*S , 2005, Molecular & Cellular Proteomics.